Epidemic Keratoconjunctivitis Clinical Presentation

  • Author: Ahmed Bawazeer, MB, ChB, FRCS(C); Chief Editor: Hampton Roy Sr, MD   more...
 
Updated: Aug 26, 2011
 

History

Epidemic keratoconjunctivitis infection may be preceded by flulike symptoms, including fever, malaise, respiratory symptoms, nausea, vomiting, diarrhea, and myalgia.

Often, a recent history of an eye examination or exposure within the family or at work is present.

The incubation period is 2-14 days, and the person may remain infectious for 10-14 days after symptoms develop.

The ocular symptoms are mainly sudden onset of irritation, soreness, red eye, photophobia, foreign body sensation, and excessive tearing.

In more severe cases, patients can present with ocular and periorbital pain and decreased visual acuity.

Symptoms tend to last for 7-21 days. The fellow eye tends to be involved in more than 50% of the cases within 7 days of onset. The signs and symptoms are typically less severe in the fellow eye.

Next

Physical Examination

Ipsilateral preauricular lymphadenopathy is one of the classic findings of epidemic keratoconjunctivitis (EKC).

Decreased visual acuity is rarely present; it is usually present only if there is corneal involvement.

Other clinical signs include the following:

  • Swelling and erythema of the lid
  • Conjunctival hyperemia
  • Chemosis
  • Follicular reaction, mainly in the lower palpebral conjunctiva (the earliest and most common sign)
  • Papillary hypertrophy
  • Subconjunctival and petechial hemorrhage

In severe cases, membranous and pseudomembranous conjunctivitis can be seen in one third of cases, which can lead to conjunctival scarring and symblepharon (seen in the image below).

Symblepharon secondary to epidemic keratoconjunctiSymblepharon secondary to epidemic keratoconjunctivitis.

Corneal involvement

One of the distinguishing features of EKC is corneal involvement, which is usually mild and transient.

Corneal involvement has been well documented 3-4 days after symptom onset in the form of diffuse, fine epithelial keratitis that stains with fluorescein and rose bengal. This keratitis can persist for 2-3 weeks. In rare cases, a frank corneal epithelial defect may occur.

One week after the onset, focal epithelial keratitis may develop. This is characterized by central ulceration and irregular borders with gray-white dots. These epithelial changes are related to active viral infection. These lesions persist for 1-2 weeks.

About 2 weeks after onset, subepithelial infiltrates can appear beneath the focal epithelial lesions, persisting for weeks to years. They resolve spontaneously, usually without scarring. These infiltrates are immunologic in nature.

In rare cases, disciform keratitis or anterior uveitis can occur.

There is no change in corneal sensation.

Previous
 
 
Contributor Information and Disclosures
Author

Ahmed Bawazeer, MB, ChB, FRCS(C)  Associate Professor and Chairman of Ophthalmology, Department of Ophthalmology, Division of Uveitis and Cornea, King Abdulaziz University, Saudi Arabia

Ahmed Bawazeer, MB, ChB, FRCS(C) is a member of the following medical societies: American Academy of Ophthalmology

Disclosure: Nothing to disclose.

Coauthor(s)

William G Hodge, MD, PhD, FRCSC  Professor and Chair, Ophthalmologist in Chief, Ivey Eye Institute, Schulich School of Medicine and Dentistry, University of Western Ontario

William G Hodge, MD, PhD, FRCSC is a member of the following medical societies: American Academy of Ophthalmology, Canadian Medical Association, Canadian Ophthalmological Society, Ontario Medical Association, Quebec Medical Association, and Royal College of Physicians and Surgeons of Canada

Disclosure: Nothing to disclose.

Specialty Editor Board

Simon K Law, MD, PharmD  Associate Professor of Ophthalmology, Jules Stein Eye Institute, University of California, Los Angeles, David Geffen School of Medicine

Simon K Law, MD, PharmD is a member of the following medical societies: American Academy of Ophthalmology, American Glaucoma Society, and Association for Research in Vision and Ophthalmology

Disclosure: Nothing to disclose.

Christopher J Rapuano, MD  Professor, Department of Ophthalmology, Jefferson Medical College of Thomas Jefferson University; Director of the Cornea Service, Co-Director of Refractive Surgery Department, Wills Eye Institute

Christopher J Rapuano, MD is a member of the following medical societies: American Academy of Ophthalmology, American Society of Cataract and Refractive Surgery, Contact Lens Association of Ophthalmologists, Cornea Society, Eye Bank Association of America, International Society of Refractive Surgery, and Pan-American Association of Ophthalmology

Disclosure: Allergan Honoraria Speaking and teaching; Allergan Consulting fee Consulting; Alcon Honoraria Speaking and teaching; Inspire Honoraria Speaking and teaching; RPS Ownership interest Other; Vistakon Honoraria Speaking and teaching; EyeGate Pharma Consulting; Inspire Consulting fee Consulting; Bausch & Lomb Honoraria Speaking and teaching; Bausch & Lomb Consulting fee Consulting

Chief Editor

Hampton Roy Sr, MD  Associate Clinical Professor, Department of Ophthalmology, University of Arkansas for Medical Sciences

Hampton Roy Sr, MD is a member of the following medical societies: American Academy of Ophthalmology, American College of Surgeons, and Pan-American Association of Ophthalmology

Disclosure: Nothing to disclose.

References
  1. Romanowski EG, Yates KA, Gordon YJ. Antiviral prophylaxis with twice daily topical cidofovir protects against challenge in the adenovirus type 5/New Zealand rabbit ocular model. Antiviral Res. Dec 2001;52(3):275-80. [Medline].

  2. Hillenkamp J, Reinhard T, Ross RS, Bohringer D, Cartsburg O, Roggendorf M, et al. The effects of cidofovir 1% with and without cyclosporin a 1% as a topical treatment of acute adenoviral keratoconjunctivitis: a controlled clinical pilot study. Ophthalmology. May 2002;109(5):845-50. [Medline].

  3. Yamazaki ES, Ferraz CA, Hazarbassanov RM, Allemann N, Campos M. Phototherapeutic keratectomy for the treatment of corneal opacities after epidemic keratoconjunctivitis. Am J Ophthalmol. Jan 2011;151(1):35-43.e1. [Medline].

  4. Sambursky R, Tauber S, Schirra F, Kozich K, Davidson R, Cohen EJ. The RPS adeno detector for diagnosing adenoviral conjunctivitis. Ophthalmology. Oct 2006;113(10):1758-64. [Medline].

Previous
Next
 
Follicular conjunctivitis and subconjunctival hemorrhage.
Symblepharon secondary to epidemic keratoconjunctivitis.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.